Login

If you are a member of the general public and not a healthcare professional, NOVELTY study investigator or AstraZeneca Medical employee, please CLICK HERE to see information tailored to you.

9th September, 2023

NOVELTY at ERS 2023

Home > News > NOVELTY at ERS 2023

We are pleased to announce that ten NOVELTY abstracts were presented at the European Respiratory Society (ERS) International Congress 2023, which was held on 9–13 September in Milan, Italy. Summaries of these abstracts, which are now published in the European Respiratory Journal, are available. The publications help to support the primary and secondary objectives of NOVELTY, which have been previously described by Reddel et al., with key findings highlighted below:

Posters

Oral presentations

The large NOVELTY presence at ERS 2023 further supports the overall goal of NOVELTY to provide real-world evidence to advance the development of precision medicine in obstructive lung disease and help advance practice change to improve patient outcomes.

19 PARTICIPATING COUNTRIESa
~12,000 ENROLLED PATIENTSa
84% OF PATIENTS HAVE SPIROMETRY DATAb

You are now leaving: http://aznoveltyproject.com/

By following this link you will be leaving the NOVELTY study website.

Please note that AstraZeneca does not take responsibility for the content displayed on other websites.

Continue Return to NOVELTY study